Streetbeat News

Analyst Ratings

IMAX

Wedbush analyst Alicia Reese has maintained an Outperform rating on Imax and raised the price target from $24 to $26.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 4:06 pm

MTB

JPMorgan analyst Steven Alexopoulos upgraded M&T Bank (NYSE:MTB) from Neutral to Overweight, raising the price target from $183 to $215. The analyst believes that the Federal Reserve's potential rate cuts could improve M&T Bank's credit metrics and earnings growth, leading to stock outperformance.

Portfolio Pulse from Priya Nigam

September 03, 2024 | 4:04 pm

DK

Analysts have mixed ratings on Delek US Holdings (NYSE:DK), with a recent trend towards bearish sentiment. The average 12-month price target has decreased by 10.5% to $22.67. Analysts have adjusted their ratings and price targets, reflecting concerns over Delek's financial performance, including a revenue decline and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:01 pm

JNJ

Johnson & Johnson (NYSE:JNJ) has received diverse analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target is $190.31, slightly down from the previous $192.08. Analysts have maintained or adjusted their ratings based on market conditions, with some lowering their price targets. JNJ's financial health shows strong net margins and asset utilization, but challenges in ROE compared to industry averages.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:00 pm

HASI

Analysts have provided mixed ratings for HA Sustainable (NYSE:HASI) over the past three months, with a trend towards more bullish perspectives. The average 12-month price target has increased by 20.63% to $38.6. Analysts have raised their ratings and price targets, reflecting positive sentiment towards the company's financial performance and growth prospects.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:00 pm

MTB

Analysts have mixed evaluations for M&T Bank (NYSE:MTB) with a recent increase in average price target to $181.47. Despite some financial challenges, several analysts have raised their ratings and price targets, indicating a positive outlook.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:00 pm

STE

Steris (NYSE:STE) has been analyzed by 4 analysts in the last three months, with all ratings being somewhat bullish. The average 12-month price target is $263.75, reflecting a 0.96% increase from the previous target. Analysts have maintained or raised their ratings, indicating positive sentiment. Steris, a leader in sterilization services, has shown solid revenue growth but faces challenges in ROE and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:00 pm

CXM

Sprinklr (NYSE:CXM) has been analyzed by 11 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has decreased by 26.27% to $11.73. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Sprinklr's financial metrics show strong net margin, ROE, and ROA, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 4:00 pm

CNK

Wedbush analyst Michael Pachter has maintained an 'Outperform' rating on Cinemark Holdings (NYSE:CNK) and raised the price target from $28 to $31.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 3:54 pm

WLDN

Wedbush analyst Jay McCanless has assumed coverage of Willdan Group (NASDAQ:WLDN) with an Outperform rating and set a price target of $51.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 3:48 pm